Evidence map›Paper›PMID 42784777›Full record

Observational studyNeurology2026

Sustained Benefits of a Multidomain Lifestyle Intervention in Multiple Sclerosis in the LIMS Study: A 24-Month Follow-Up.

Arianne S Gravesteijn, Ilse M Nauta, Meike Stob, Nathalie Wilmsen, Emma Coles, Vincent de Groot, Zoe L E van Kempen, Joep Killestein, Bob W Van Oosten, Eva M Strijbis and 2 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05402501 (Lifestyle Intervention for Patients With Multiple Sclerosis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05402501 unknown statusnot on this map

Lifestyle Intervention for Patients With Multiple Sclerosis

TypeobservationalSponsorAmsterdam UMC, location VUmcRan2021 to 2024Enrolled900ConditionsMultiple SclerosisArmsLifestyle intervention program "Leef! met MS"
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Arianne S GravesteijnAmsterdam UMC Location Vrije Universiteit Amsterdam, Rehabilitation Medicine, the Netherlands.ORCID 0000-0002-2458-2346
Ilse M NautaAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.ORCID 0000-0002-5817-6696
Meike StobMS Center Amsterdam, the Netherlands.
Nathalie WilmsenVoeding Leeft, Amsterdam, the Netherlands; and.ORCID 0000-0002-1184-3893
Emma ColesVoeding Leeft, Amsterdam, the Netherlands; and.ORCID 0009-0007-9589-7509
Vincent de GrootAmsterdam UMC Location Vrije Universiteit Amsterdam, Rehabilitation Medicine, the Netherlands.ORCID 0000-0002-6073-6250
Zoe L E van KempenAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.
Joep KillesteinAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.ORCID 0000-0002-6347-5957
Bob W Van OostenAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.ORCID 0000-0003-4536-6201
Eva M StrijbisAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.ORCID 0000-0001-6705-5864
Bernard M J UitdehaagAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.ORCID 0000-0002-9226-7364
Brigit A de JongAmsterdam Neuroscience, Neuroinfection and Neuroinflammation, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesMultiple sclerosis (MS) often leads to physical, cognitive, and psychological impairments substantially affecting daily functioning and quality of life. Because current disease-modifying therapies do not fully prevent disease progression, interest has grown in the potential role of modifiable lifestyle factors. We evaluated (1) whether effects on patient-reported outcomes were sustained up to 24 months and (2) long-term changes in lifestyle behaviors after completion of the lifestyle in MS program.

methodsPeople with MS participated in a 3-month multimodal lifestyle program (i.e., Mediterranean-style diet, physical activity, and sleep and stress), followed by a 21-month maintenance phase. Patient-reported outcomes were assessed 3 months before the intervention, at baseline, postintervention, and after 6, 12, 18, and 24 months. The primary outcome was MS-related impact on daily functioning (MS Impact Scale-29 [MSIS-29]). Secondary outcomes included quality of life, general health, and MS-related symptoms. Longitudinal changes were analyzed using piecewise mixed-effects models, and individual-level change was evaluated using proportions exceeding the smallest detectable change (SDC).

resultsIn total, 659 participants were included (mean age 46 years, SD 11; 84% female). During the intervention phase, MSIS-29 physical and psychological scores significantly decreased by approximately 0.8 and 1.1 points per month, respectively, followed by attenuation during long-term follow-up. This was reflected by within-group changes of -2.7 (-3.7; -1.8) and -3.7 (-4.8; -1.6) points after the intervention and -0.8 (-1.7; 0.3) and -3.4 (-4.6; -2.3) point at month 24, remaining significantly improved or stable relative to baseline. Only a small proportion of participants exceeded the SDC for MSIS-29 (approximately 4%-7%). Trajectories were broadly similar across other patient-reported outcomes, with modest short-term improvements and subsequent stabilization. Most pronounced effects were found for dietary adherence and body mass index, which improved substantially during the intervention and remained partially sustained during follow-up. No significant changes were observed in physical activity adherence. DISCUSSION: In this large, real-world study, a digital multimodal lifestyle intervention was associated with modest, mainly short-term improvements in patient-reported outcomes and more pronounced individual-level changes in dietary behavior and body composition. These findings support a complementary role for lifestyle interventions in long-term MS management. TRIAL REGISTRATION INFORMATION: The study was registered at ClinicalTrials.gov (Identifier: NCT05402501; classic.clinicaltrials.gov/ct2/show/NCT05402501).

Indexed as

Life StyleMultiple SclerosisAdultDiet, MediterraneanExerciseFemaleFollow-Up StudiesHumansMaleMiddle AgedPatient Reported Outcome MeasuresQuality of LifeSleepStress, PsychologicalTreatment Outcome

Identifiers

PMID42784777
PMCPMC13618009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.